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Overexpression of Pyruvate Dehydrogenase Kinase 1 and
Lactate Dehydrogenase A in Nerve Cells Confers Resistance
to Amyloid ␤ and Other Toxins by Decreasing Mitochondrial
Respiration and Reactive Oxygen Species Production*□
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Jordan T. Newington‡1, Tim Rappon‡, Shawn Albers§, Daisy Y. Wong§, R. Jane Rylett§, and Robert C. Cumming‡2
From the ‡Department of Biology, University of Western Ontario, London, Ontario N6A 5B7 and the §Department of Physiology
and Pharmacology and Molecular Brain Research Group, Robarts Research Institute, London, Ontario N6A 5K8, Canada
Background: Aerobic glycolysis promotes resistance against A␤ toxicity.
Results: Increased LDHA and PDK1 expression attenuates mitochondrial activity and confers resistance to A␤. These proteins
are down-regulated in a transgenic Alzheimer disease (AD) mouse model, and PDK1 is decreased in AD brain.
Conclusion: PDK and LDHA are central mediators of A␤ resistance.
Significance: Drugs that augment aerobic glycolysis may enhance brain cell survival in AD patients.
We previously demonstrated that nerve cell lines selected for
resistance to amyloid ␤ (A␤) peptide exhibit elevated aerobic
glycolysis in part due to increased expression of pyruvate dehydrogenase kinase 1 (PDK1) and lactate dehydrogenase A
(LDHA). Here, we show that overexpression of either PDK1 or
LDHA in a rat CNS cell line (B12) confers resistance to A␤ and
other neurotoxins. Treatment of A␤-sensitive cells with various
toxins resulted in mitochondrial hyperpolarization, immediately followed by rapid depolarization and cell death, events
accompanied by increased production of cellular reactive oxygen species (ROS). In contrast, cells expressing either PDK1 or
LDHA maintained a lower mitochondrial membrane potential
and decreased ROS production with or without exposure to toxins. Additionally, PDK1- and LDHA-overexpressing cells exhibited decreased oxygen consumption but maintained levels of
ATP under both normal culture conditions and following A␤
treatment. Interestingly, immunoblot analysis of wild type
mouse primary cortical neurons treated with A␤ or cortical tissue extracts from 12-month-old APPswe/PS1dE9 transgenic
mice showed decreased expression of LDHA and PDK1 when
compared with controls. Additionally, post-mortem brain
extracts from patients with Alzheimer disease exhibited a
decrease in PDK1 expression compared with nondemented
patients. Collectively, these findings indicate that key Warburg
effect enzymes play a central role in mediating neuronal resistance to 〈␤ or other neurotoxins by decreasing mitochondrial
activity and subsequent ROS production. Maintenance of PDK1
or LDHA expression in certain regions of the brain may explain

why some individuals tolerate high levels of A␤ deposition without developing Alzheimer disease.

Alzheimer disease (AD)3 is a progressive neurodegenerative
disease and is the most common form of age-related dementia.
AD is characterized by widespread nerve cell death and the
accumulation of extracellular plaques and intracellular neurofibrillary tangles within the brain (1). These plaques are primarily composed of amyloid-␤ peptide (A␤), a 39 – 42-amino acid
peptide derived from the proteolytic cleavage of the amyloid
precursor protein (APP). The A␤ peptide, particularly the 42-amino acid long variant (A␤42), is highly prone to undergo oligomerization and fibrillogenesis, events strongly associated with
the disease state (2). The amyloid cascade hypothesis, first proposed over 15 years ago, suggests that A␤ deposition in the
brain is the causative agent of AD (3, 4). Although multiple
clinical trials have been conducted, i.e. testing agents that either
prevent the cleavage of APP or promote increased clearance of
A␤, to date none of these trials have been successful in halting
disease progression thus prompting the hunt for alternative
therapies to combat AD (5).
A␤ deposition promotes mitochondrial dysfunction and an
increase in reactive oxygen species (ROS) production resulting
in oxidative damage, synaptic loss, and ultimately nerve cell
death (6 –9). However, numerous immunohistochemical studies of brain tissue from individuals without any history of
dementia showed that up to 30% of the autopsied samples had
significant plaque accumulation but little or no nerve cell loss
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(10, 11). It has been argued that asymptomatic individuals with
high plaque accumulation likely had undiagnosed mild cognitive impairment and would have eventually developed AD had
they lived long enough or had a high cognitive reserve. However, an alternative hypothesis is that these individuals may
have acquired an innate resistance mechanism to the toxic
effects of A␤. Although difficult to study in patients, models of
A␤ resistance have been generated in vitro following the continual exposure of cultured nerve cells to concentrations of A␤
that would otherwise be toxic and the eventual emergence of
surviving clonal nerve cell populations. Analysis of these A␤-resistant nerve cells revealed up-regulation of anti-oxidant
enzymes compared with the sensitive parental cells (12, 13).
Additionally these cells displayed an increased resistance to a
wide array of neurotoxins, suggesting that acquisition of A␤
resistance also confers resistance to a variety of environmental
stresses (14).
Intriguingly, A␤-resistant cells also exhibit increased glucose
uptake and flux through the glycolytic pathway and heightened
sensitivity to glucose deprivation (15). These cells also appear to
break down glucose in a unique manner, reminiscent of cancer
cells. Cancer cells have been shown to shift metabolism from
mitochondrial respiration to glycolysis and lactate production
for their energy needs despite the presence of oxygen (16, 17).
This phenomenon is termed the Warburg effect, or aerobic
glycolysis, and is driven by hypoxia-inducible factor 1␣ subunit
(HIF-1␣) (18 –21). HIF-1␣ is a heterodimeric transcription factor that regulates cellular adaptation to hypoxia and induces the
transcription of pyruvate dehydrogenase kinase 1 (PDK1) (20,
21). PDK1 phosphorylates and inhibits pyruvate dehydrogenase, an enzyme responsible for the conversion of pyruvate to
acetyl-CoA (21). When pyruvate dehydrogenase is inhibited,
pyruvate is no longer an available substrate to fuel the TCA
cycle, and mitochondrial oxygen consumption is decreased
(21). Additionally, HIF-1␣ up-regulates the expression of
LDHA, an enzyme responsible for the conversion of pyruvate to
lactate, with the concomitant regeneration of nicotinamide
(NAD⫹) (22).
Although HIF-1␣ was initially believed to be only active in
low oxygen environments, recent findings have suggested that
HIF-1␣ can be up-regulated under normoxic conditions in both
normal and cancer cells (23–26). HIF-1␣-regulated changes in
metabolism not only allow for maintenance of energy homeostasis in prolonged low oxygen conditions but also attenuate
generation of harmful ROS at higher oxygen levels (20). By
repressing mitochondrial respiration, cancer cells are less likely
to produce ROS and are more resistant to mitochondrial depolarization, two events tightly linked to induction of apoptosis
(27).
Similar to cancer cells, the observed metabolic changes in
A␤-resistant cells arise through stabilization of HIF-1␣ (15). In
addition, A␤-resistant nerve cells have elevated PDK1 expression as well as an increase in LDHA activity and lactate production when compared with control cells (28). Moreover, mitochondrion-derived ROS, which are closely associated with A␤
toxicity, are markedly diminished in A␤-resistant cells compared with A␤-sensitive cells (28). Chemically or genetically
inhibiting LDHA or PDK1 re-sensitizes resistant cells to A␤
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toxicity, suggesting that the altered glycolytic metabolism in
these cells may mediate A␤ resistance (28). Although a reduction in cerebral glucose metabolism, as measured by fluoro-2deoxy-D-glucose (FDG) positron emission tomography (PET),
is one of the most common diagnostic features of AD, recent
evidence suggests that glucose utilization is more complex in
the AD brain (29, 30). Studies using modified PET imaging,
which measured both glucose consumption and oxygen utilization, revealed a strong correlation between the spatial distribution of elevated aerobic glycolysis and A␤ plaques in brain tissue from patients with AD and in normal individuals with high
levels of A␤ deposition but without clinical manifestation of the
disease (30). Additionally, the spatial distribution of A␤ deposition and increased aerobic glycolysis closely mirrors areas of
high aerobic glycolysis in the normal healthy brain (31). These
findings suggest that areas of the brain most susceptible to
insult in AD may exhibit a Warburg effect as a protective mechanism that can be further activated in the presence of high levels
of A␤. However, this hypothesis has never formally been
evaluated.
Here, we show that overexpression of LDHA or PDK1 in the
B12 central nervous system cell line confers resistance to A␤
and other neurotoxins such as H2O2 and staurosporine.
Increased survival in cells overexpressing LDHA or PDK1 is
associated with decreased mitochondrial membrane potential,
oxygen consumption, and ROS production, yet these cells
maintain the ability to produce sufficient ATP. Expression of
PDK1 and LDHA is decreased in wild type mouse primary cortical neurons exposed to A␤ and in cortical extracts from
12-month-old AD transgenic (APP/PS1) mice. Similarly, postmortem cortical tissue from AD patients also revealed a
decrease in PDK1 expression relative to control patient brain
samples. These findings suggest that loss of the adaptive advantage afforded by aerobic glycolysis may exacerbate the pathophysiological processes associated with AD.

EXPERIMENTAL PROCEDURES
Materials—Cell culture reagents, including Dulbecco’s modified Eagle’s medium (DMEM), penicillin/streptomycin,
DMEM without phenol red, and Dulbecco’s phosphate-buffered saline (DPBS), were purchased from BioWhittaker (Walkersville, MD). Dialyzed fetal bovine serum (FBS) and horse
serum were obtained from PAA Laboratories Inc. (Etobicoke,
Ontario, Canada). Opti-MEM I, TrypLE Express, neurobasal
medium, N2 supplement, B27 supplement, GlutaMAX-1
(100⫻) and Hanks’ balanced salts solution were obtained from
Invitrogen. A␤(25–35) peptide was purchased from California
Peptide Research (San Francisco). Poly-D-lysine, poly-L-ornithine, puromycin, dihydrochloride, dimethylformamide, and
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
were all purchased from Sigma. DNase I and trypsin inhibitor
were purchased from Roche Applied Science. G418 sulfate was
purchased from Calbiochem. Mitotracker Red CM-H2XRos,
tetramethylrhodamine methyl ester (TMRM), MitoSOX Red,
2⬘,7⬘-dichlorodihydrofluorescein diacetate (H2DCFDA), and
the ATP determination kit were purchased from Invitrogen.
MitoXpress-Xtra-HS was purchased from Luxcel Biosciences
Ltd. (Cork, Ireland).
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Cell Culture—The B12 rat central nervous system cell line
was obtained from Dr. David Schubert (The Salk Institute, La
Jolla, CA) and cultured as described previously (6, 13). The B12
central nervous system cells are an immortalized clonal cell line
derived from a nitrosoethylurea-induced brain tumor in rats
(32) and have been shown to be sensitive to A␤ toxicity. These
cells were grown in DMEM supplemented with 10% FBS and
1% penicillin/streptomycin. For toxicity studies, the A␤(25–35)
peptide was dissolved in deionized water at 1 mg/ml, left overnight at room temperature to promote fibril formation, and
subsequently stored at ⫺20 °C.
Derivation of PDK1- and LDHA-overexpressing Cell Lines—
For stable expression of PDK1 and LDHA, B12 cells were transfected with Lipofectamine (Invitrogen) according to the manufacturer’s directions. Cells were plated at a density to achieve
70 – 80% confluency and transfected with vectors containing
human PDK1 (pCMV6-AC) or LDHA (pCMV6-XL4) cDNA
(Origene, Rockville, MD). Additionally, cells were transfected
with an empty vector (pcDNA) as a positive control. Following
selection in G418 (1 mg/ml) for 2 weeks, ⬃10 –12 clones were
picked, expanded, and screened by immunoblot analysis for
high level expression of either PDK1 or LDHA.
Derivation of PDK1 and LDHA Knockdown Cell Lines—For
stable knockdown of PDK1 and LDHA, B12 cells were transfected with HuSH 29-mer shRNA (Origene, Rockville, MD)
constructs directed at rat Ldha or Pdk1 transcripts followed by
selection with puromycin as described previously (28). The
shRNA construct directed against Ldha was 69GCCGAGAGCATAATGAAGAACCTTAGGCG, and the shRNA construct
directed against Pdk1 was 29AATCACCAGGACAGCCAATACAAGTGGTT. A nontargeting shRNA construct (scrambled)
in pRS plasmid was used as a negative control.
Immunoblot Analysis—B12 cells from subconfluent cultures
were washed twice in cold DPBS and harvested in a Tris extraction buffer (50 mM Tris, pH 7.5, 2% SDS, and 1 mM PMSF).
Protein extracts were quantified by a Lowry assay, resolved by
12% SDS-PAGE, and electroblotted onto PVDF membrane
(Bio-Rad) (12). Membranes were probed with the following
antibodies: polyclonal anti-LDHA (1:1000; Cell Signaling, Danvers, MA), polyclonal anti-PDK1 (1:1000; StressGen, San
Diego), and a monoclonal anti-␤-actin (1:2000; Cell Signaling,
Danvers, MA) followed by incubation with an appropriate
horseradish peroxidase-conjugated secondary antibody (BioRad). The blots were developed using Pierce ECL Western blotting substrate (Thermo Scientific, Rockford, IL) and visualized
with a Bio-Rad molecular imager (ChemiDoc XRS). Densitometric analysis was performed using ImageJ software. Band
densities were standardized against ␤-actin, and the ratio of
LDHA- or PDK1-specific bands relative to the ␤-actin band was
determined. Relative intensity was calculated by comparing the
LDHA/␤-actin or PDK1/␤-actin ratios of the transfected lines
to the same ratio in the control cell line.
Cytotoxicity Assay—A␤-, hydrogen peroxide-, and staurosporine-induced cytotoxicity was assessed by a modified 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
(6, 13, 33). Cells were seeded (3 ⫻ 103 cells/well) in a 96-well
microtiter plate, and A␤(25–35) was added to the test wells at a
concentration of 20 M and incubated for 48 h. To each well
OCTOBER 26, 2012 • VOLUME 287 • NUMBER 44

10 l of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (2.5 mg/ml dissolved in DPBS) was added, and following a 4-h incubation, 100 l of solubilization solution (20% SDS
in 50% dimethylformamide, pH 4.8) was added to each well.
The plates were rocked at room temperature overnight and
then read on a microplate reader (Bio-Rad model 3550) using
595 nm as the test wavelength and 655 nm as the reference
wavelength. The percent viability was calculated from the mean
absorbance of the treated cells divided by the mean absorbance
of the control cells and multiplied by 100%.
Oxygen Consumption—Oxygen consumption was monitored
using the fluorescent oxygen probe MitoXpress-Xtra-HS. B12
cells (1.25 ⫻ 105) were seeded on 60-mm dishes. The following
day, A␤(25–35) (20 M) was added to the treatment dishes, and
cells were incubated for 48 h. Cells were trypsinized, centrifuged, and resuspended at an appropriate density prior to the
assay. Cells (2 ⫻ 105) were transferred to a 96-well plate and
incubated with the MitoXpress probe according to the manufacturer’s instructions (Luxcel Biosciences Ltd.). Oxygen consumption was monitored as a function of fluorescence (excitation/emission 380/650 nm) every 2 min over a 6-h period on a
time-resolved fluorescence microplate reader (Tecan, Infinite
M1000). Data were analyzed using the program Mathematica
as described previously (34). Oxygen concentration in micromolars was calculated by Equation 1, where X is the normalized
fold change in fluorescence over the initial reading, 235 M is
the concentration of oxygen gas in fully saturated water at
30 °C, and S is the signal increase on deoxygenation.

关 O2](t兲 ⫽

235共S ⫺ X兲
X共S ⫺ 1)

(Eq. 1)

Linear regression over a span of 100 min was performed to
determine the rate of oxygen consumption for each clone. Oxygen consumption rates were later standardized to cell number.
ATP Production—Cellular ATP was measured in B12 cells
using a bioluminescence ATP determination kit. Approximately 7.5 ⫻ 104 cells were plated in 35-mm dishes and the
following day were treated with A␤(25–35) (20 M) for a further 48 h. Cells were harvested in a Tris extraction buffer (20
mM Tris, pH 7.8, 2 mM EDTA, 0.5% Nonidet P-40, and 25 mM
NaCl). One microgram of protein sample was loaded in each
well of a 96-well plate. The luciferin and luciferase buffers were
prepared according to the manufacturer’s instructions (Molecular Probes), and 100 l was injected into each well. Luminescence was integrated over 10 s using a TECAN Infinite M1000
microplate reader. ATP contents were calculated by comparing
the luminescence, using an ATP standard curve.
Fluorescence Microscopy—Mitochondrial membrane potential (⌬m) was visualized by the fluorescent dye TMRM (17).
B12 cells were seeded between 1 ⫻ 105 and 2 ⫻ 105 cells on
30-mm plastic tissue culture dishes pretreated with polylysine
and incubated overnight. The following day, cells were treated
with 20 M A␤(25–35) for 48 h. Following treatment with A␤,
the media were aspirated, and new media were added containing TMRM at a concentration of 200 nM. Plates were then incubated at 37 °C for 20 min, washed in DPBS containing Hoechst
stain (10 g/ml), followed by an additional wash in DPBS, and
JOURNAL OF BIOLOGICAL CHEMISTRY
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then placed in phenol red-free DMEM. For treatment with
H2O2 or staurosporine, cells were first stained using the above
protocol. Following staining, cells were treated with either
H2O2 (200 M) or staurosporine (200 ng/ml) for 15 min before
visualization. Cells were visualized by fluorescence microscopy
(Zeiss-AxioObserver, ⫻40 objective), and pictures were taken
using an Q Imaging (Retiga 1300 monochrome 10-bit) camera
with Q Capture software. Pictures were taken of three random
fields of view for each experiment. TMRM fluorescence was
quantified with ImageJ software.
Mitochondrial ROS production was visualized by the fluorescent dye Mitotracker Red CM-H2XRos (MTR). B12 cells
were plated and seeded between 1 and 2 ⫻ 105 cells on 30-mm
plastic tissue culture dishes pretreated with polylysine and
incubated overnight. The following day, the cells were treated
with 20 M A␤(25–35) for 48 h. Following treatment with A␤,
the media were aspirated, and new media were added containing MTR at a concentration of 100 nM. Plates were then incubated at 37 °C for 20 min, washed in DPBS containing Hoechst
stain, followed by an additional wash in DPBS, and then placed
in phenol red-free DMEM. For treatment with H2O2 or staurosporine, cells were first treated with either H2O2 (200 M) or
staurosporine (200 ng/ml) for 30 min before visualization and
then stained and visualized as described above. MTR fluorescence was quantified with ImageJ software. Mitochondrionderived superoxide was also visualized using the fluorescent
dye MitoSOX Red mitochondrial superoxide indicator. Glass
bottom dishes were pretreated with polylysine, and cells were
plated and treated as described above. Cells were stained with
MitoSOX at 5 M and incubated at 37 °C for 30 min. Plates were
then washed in DPBS containing Hoechst stain and then placed
in phenol red-free DMEM. Cells were visualized by fluorescence microscopy (Zeiss-AxioObserver, ⫻100 objective), and
fluorescence was quantified as described above.
Overall, cellular ROS was visualized by the fluorescent dye
5-(and-6)-chloromethyl-2⬘,7⬘-dichlorodihydrofluorescein diacetate (CM-H2DCFDA). Cells were plated and treated as described
above. Cells were stained with CM-H2DCFDA at 2.5 M and incubated at 37 °C for 15 min. Plates were then washed once in PBS
then visualized as described above. H2DCFDA fluorescence was
quantified with ImageJ software.
For time-lapse microscopy, B12 cells were seeded at 2 ⫻ 105
cells in a 6-well Chamlide TC stage chamber (Live Cell Instruments, Nowan-gu, Seoul, Korea) pretreated with polylysine (50
g/ml) and incubated overnight at 37 °C in a tissue culture
incubator. The following day, cells were stained with TMRM as
described above. Following staining, the stage chamber was
assembled onto the automated stage of a DMI6000 B inverted
microscope (Leica Microsystems, Wetzlar, Germany) heated to
37 °C and perfused with 5% CO2 using an FC-5 CO2/air gas
mixer (Live Cell Instrument, Nowan-gu, Seoul, Korea). Cells
were treated with H2O2 (200 M) and time-lapse differential
interference contrast, and fluorescent images of cells were
automatically captured from three independent fields of each
well every 10 min over 4 h using a C10600 Hamamatsu digital
camera (Meyer Instruments, Houston, TX) equipped with
Metamorph software. The differential interference contrast
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and fluorescent images were overlaid, and a time-lapse video
was generated using ImageJ software.
Primary Nerve Cell Cultures—Primary cortical neurons were
prepared from mouse embryonic day 14 –17 as described previously (35). Cells were seeded at a density of 1.6 ⫻ 106 cells per
dish and cultured in Neurobasal media containing 2 mM glutamine, 50 units/ml penicillin/streptomycin, and N2/B27 supplements and incubated for 48 h (35). The media were changed
48 h post-plating. At this time cells were treated with 10 M
A␤(25–35). Cells were harvested in 2% SDS buffer as described
above at 4, 8, 12, 16, 24, 36, and 48 h post-A␤ treatment. PDK1
and LDHA were visualized by Western blot analysis as
described above, and protein quantification was performed
using ImageJ software.
Mouse and Human Tissue—Cortical brain tissues from APP/
PS1 (APPswe, PSEN1dE9) double transgenic mice were generously provided by Dr. David Schubert (The Salk Institute, La
Jolla, CA). Twelve-month-old tg-AD mice and age matched
controls were perfused with saline and protease inhibitor mixture, and brain regions were snap-frozen and stored at ⫺80 °C.
Frozen tissue samples were partially thawed, and ⬃100-mg
pieces were removed and minced in a 5⫻ weight/volume
extraction buffer containing 50 mM Tris, pH 7.5, 2% SDS, and
protease inhibitor mixture (12, 15). Following sonication and
centrifugation, supernatants were collected, and protein
extracts were quantified using the Lowry assay. Protein extracts
(15 g) from the frontal cortex were analyzed by immunoblot
analysis as described above.
Autopsied brain samples were obtained from Drs. Carol
Miller and Jenny Tang at the Alzheimer Disease Research Center (University of Southern California School of Medicine, Los
Angeles, CA). All tissue samples were extracted from the same
area of the mid-frontal cortex and immediately quick frozen
after removal. All AD and control cases were matched pairwise
for age, sex, and in most cases post-mortem interval. All AD
patients had a clinical history of dementia and a plaque density
(plaques per field, PPF) in the low to moderate range according
to The Consortium to Establish a Registry for Alzheimer disease criterion (1 ⫽ sparse, 1–5 PPF; 3 ⫽ moderate, 6 –20 PPF;
5 ⫽ frequent, 21–30 PPF or above). Patient details are summarized in Table 1. Frozen tissue samples were partially thawed,
and ⬃100-mg pieces were removed and minced in a 5⫻ weight/
volume extraction buffer containing 50 mM Tris, pH 7.5, 2%
SDS, and protease inhibitor mixture (12, 15). Following sonication and centrifugation, supernatants were collected, and protein extracts were quantified using the Lowry assay. Protein
extracts (15 g) were analyzed by immunoblot analysis as
described above.
Statistical Analysis—Data are presented as means ⫾ S.D.
resulting from at least three independent experiments. Data
were analyzed statistically using a one-way ANOVA followed
by a Tukey test (Vassar Stats). The oxygen consumption and
primary nerve cell data were analyzed by a one-way ANOVA,
and significant differences between means were determined by
contrasts (Mathematica). Results were considered statistically
significant at p ⬍ 0.05.
VOLUME 287 • NUMBER 44 • OCTOBER 26, 2012

PDK1 and LDHA Mediate Resistance to A␤
TABLE 1
Control and AD patient details

a
b

Patient

Diagnosis

Age

C1
A1
C2
A2
C3
A3
C4
A4
C5
A5
C6
A6
C7
A7
C8
A8

Normal
AD
Normal
AD
Normal
AD
Normal
AD
Normal
AD
Normal
AD
Normal
AD
Normal
AD

94
95
87
86
88
85
69
75
91
90
92
90
80
77
71
72

Sex

PMIa

PPF

Female
Female
Female
Female
Male
Male
Male
Male
Female
Female
Female
Female
Male
Male
Female
Female

4.5
4.5
6
6
2
4.5
8
2
NAb
4.5
7
7.5
12
3
11
5

0
3
0
1
0
1
0
5
0
5
0
3
0
5
0
5

PMI, post-mortem interval.
NA, not available.

RESULTS
Overexpression of LDHA or PDK1 Confers Resistance to A␤,
H2O2, and Staurosporine Toxicity—LDHA and PDK1 are key
enzymes that mediate the Warburg effect in cancer cells (17–
19, 36). Previous studies have shown that increased PDK1
expression, LDHA activity, and lactate production are common
features of A␤-resistant cells (28). Therefore, we sought to
determine whether overexpression of either LDHA or PDK1 in
B12 A␤-sensitive cells could confer resistance to A␤ toxicity.
Western blot analysis of B12 cells transfected with vectors containing human LDHA or PDK1 cDNAs revealed elevated constitutive expression of LDHA or PDK1 compared with cells
transfected with the control plasmid (pcDNA) (Fig. 1, A and B).
B12 cells overexpressing LDHA or PDK1 exhibited a significant
increase in cell viability following 48 h of exposure to A␤(20
M) when compared with control cells (Fig. 1C).
Clonal nerve cell lines selected for resistance to A␤ toxicity
have been shown to exhibit increased resistance to a wide array
of neurotoxins (13, 14). We were therefore interested to see if
overexpression of either LDHA or PDK1 conferred resistance
to other stressors. The sensitivity of LDHA- and PDK1-overexpressing cells to glutamate, H2O2, staurosporine, and a variety
of mitochondrial inhibitors (rotenone, antimycin, and oligomycin) was examined. Interestingly, none of the overexpressing
lines were more resistant to any of the mitochondrial inhibitors
or glutamate (data not shown). However, all LDHA- and PDK1overexpressing cell lines showed an increased resistance to
H2O2 (200 M) and staurosporine (200 ng/ml; Fig. 1, D and E).
Therefore, the overexpression of either LDHA or PDK1 confers
resistance to H2O2 and staurosporine but not to neurotoxins
that specifically disrupt the mitochondrial electron transport
chain (ETC).
Attenuated LDHA and PDK1 Re-sensitize Cells to A␤, H2O2,
and Staurosporine Toxicity—Although we have previously
shown that attenuation of LDHA and PDK1 in PC12 and B12
reversed A␤ toxicity in these cells, we sought to determine
whether specific inhibition of LDHA and PDK1 expression by
shRNA-mediated knockdown could also render B12 parental
cells more sensitive to A␤ (28). Immunoblot analysis confirmed
B12 cell lines stably transfected with shRNA directed at rat ldha
or pdk1 transcripts exhibited decreased expression of the tarOCTOBER 26, 2012 • VOLUME 287 • NUMBER 44

geted mRNAs compared with cells transfected with a control
shRNA containing a nonspecific/scrambled sequence (supplemental Fig. 1). Knockdown of either ldha or pdk1 in the B12
cells resulted in a significant decrease in cell viability, following
48 h of exposure to A␤ or 24 h of exposure to H2O2 or staurosporine when compared with the control (supplemental Fig. 1,
C–E, p ⬍ 0.01). Thus attenuation of LDHA or PDK1 appears to
further sensitize B12 cells to a variety of neurotoxins.
Decreased Mitochondrial Membrane Potential in LDHAand PDK1-overexpressing Cells—Mitochondrial membrane
potential is generated by oxidative phosphorylation (OXOPHOS) activity; thus, a decrease in mitochondrial membrane
potential is indicative of decreased electron transport and
OXOPHOS activity (17). Both elevated PDK1 and LDHA
expressions have been tied to reduced mitochondrial OXOPHOS activity, and therefore we sought to determine whether
overexpression of LDHA or PDK1 could result in decreased
mitochondrial membrane potential (⌬m) following treatment
with A␤, H2O2, and staurosporine. Indeed, all overexpressing
cell lines had significantly less ⌬m as measured by reduced
TMRM fluorescence, compared with control cells expressing
plasmid alone (Fig. 2). When control cells were treated for 48 h
with A␤ (20 M), there was a significant increase in ⌬m (p ⬍
0.01), whereas ⌬m remained unaltered in both LDHA- and
PDK1-overexpressing cell lines compared with untreated cells.
Similar results were obtained when cells were treated with
either H2O2 (200 M) or staurosporine (200 ng/ml) for 30 min,
namely the control cells showed a significant increase in membrane potential (p ⬍ 0.01), whereas all the LDHA- and PDK1overexpressing cell lines significantly maintained ⌬m. Timelapse microscopy revealed that control cells displayed increased
⌬m or hyper-polarization, followed by rapid depolarization
and cell death when exposed to H2O2 (200 M) (supplemental
Video 1). In contrast, LDHA- and PDK-overexpressing cells
showed decreased ⌬m under control conditions, which was
maintained when cells were exposed to H2O2 (200 M). Furthermore, the majority of cells overexpressing either LDHA or
PDK1 did not undergo mitochondrial membrane depolarization and subsequent cell death following treatment with H2O2.
Taken together, overexpression of either LDHA or PDK1
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 1. Overexpression of LDHA or PDK1 increases resistance to A␤ and other toxins in B12-sensitive cells. A, immunoblot analysis of B12 A␤-sensitive
cells stably transfected with either pcDNA (empty vector) or a vector containing human LDHA cDNA revealed two clonal cell lines (clones 3 and 7) with markedly
increased LDHA protein levels (*, p ⬍ 0.01). B, immunoblot analysis of extracts from two clonal cell lines (clones 6 and 7) stably transfected with a PDK1
expression vector confirmed a significant increase in PDK1 protein expression compared with the control cell line (**, p ⬍ 0.05). An additional 30-kDa PDK1
band was also elevated in PDK1-transfected cells and likely represents a cleavage product. Densitometric analyses of LDHA and PDK1 band intensities are
indicated below each blot. Cell viability of clonal lines overexpressing either LDHA or PDK1 was significantly increased following exposure to either A␤ (20 M)
for 48 h (C), H2O2 (200 M) for 24 h (D), or staurosporine (200 ng/ml) for 24 h (E) compared with the control cell line (*, p ⬍ 0.01).

resulted in decreased ⌬m, which is maintained following
exposure to a variety of stressors.
Overexpression of LDHA or PDK1 Decreases Oxygen Consumption but Maintains ATP Levels in the Presence of A␤—The
overexpression PDK1 or LDHA is believed to be sufficient to
shift metabolism away from mitochondrial respiration toward
increased lactate production (17, 36). Thus, we sought to determine whether the overexpression of these enzymes in B12 cells
would result in a reduction in oxygen (O2) consumption, a
measure of mitochondrial respiration. O2 consumption was
monitored in B12 cells stably expressing LDHA or PDK1 using
MitoXpress-Xtra-HS, a fluorescent oxygen probe. Under control conditions, all PDK1- and LDHA-expressing clonal lines
exhibited significantly decreased O2 consumption compared
with the pcDNA control (Fig. 3A, p ⬍ 0.05). Interestingly, 48 h
of A␤(25–35) (20 M) treatment resulted in decreased O2 consumption in the pcDNA control line but had little effect on the
overexpressing clones (Fig. 3, p ⬍ 0.05).
Considering that mitochondrial respiration is a far more efficient way of producing energy compared with lactate production, we sought to determine whether the observed decreased
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O2 consumption affected the levels of ATP in cells overexpressing LDHA or PDK1. Intracellular ATP levels were measured in
the B12-overexpressing cell lines cultured in the absence or
presence of 20 M A␤ for 48 h. Under control conditions, all
B12 cell lines had similar levels of ATP (Fig. 3D). However, A␤
treatment resulted in a 50% reduction in ATP levels in B12
control cells (pcDNA) (Fig. 3D, p ⬍ 0.05). Interestingly all
PDK1- and LDHA-overexpressing clones maintained significantly higher levels of ATP production in the presence of A␤
compared with control cells under the same conditions (Fig.
3D, p ⬍ 0.05). These results suggest that cells that are less
dependent on mitochondrial respiration are also less sensitive
to A␤-induced alterations in glucose metabolism and are able
to maintain ATP levels in the presence of A␤.
Attenuated Mitochondrial and Cellular ROS in LDHA- and
PDK1-overexpressing B12 Cells—Reduced mitochondrial ROS
is associated with the Warburg effect and was previously
observed in A␤-resistant cells with innately high PDK1 and
LDHA activity (17, 28, 37). Therefore, we sought to determine
whether overexpression of either PDK1 or LDHA in A␤-sensitive cells could reduce mitochondrial ROS when exposed to A␤
VOLUME 287 • NUMBER 44 • OCTOBER 26, 2012
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FIGURE 2. Decreased mitochondrial membrane potential in LDHA- and PDK 1-overexpressing cells. Top panels, mitochondrial membrane potential
(⌬m) was measured in B12 cells following staining with the red fluorescing dye TMRM. Both PDK1- and LDHA-overexpressing B12 cell lines exhibited a
significant reduction in ⌬m under normal culture conditions compared with the control cell line expressing the empty vector (pcDNA) (*, p ⬍ 0.01). Cells
expressing the empty vector (pcDNA) showed a significant increase in ⌬m following exposure to A␤ (20 M), H2O2 (200 M), or staurosporine (200 ng/ml)
compared with PDK1- and LDHA-overexpressing cells. As a counterstain, nuclei were stained with Hoechst (blue) and visualized by fluorescence microscopy at
⫻400 magnification. Bottom panels, quantification of TMRM fluorescence intensity revealed that ⌬m was consistently lower in PDK- and LDHA-overexpressing cells in the absence (⫺) or presence (⫹) of the indicated stressor when compared with the pcDNA control cell line. Data presented are the average of three
independent experiments.

or other stressors. We examined mitochondrial ROS in control
and LDHA/PDK1-overexpressing cells using MTR CM-H2XRos,
a mitochondrial specific dye that fluoresces when oxidized by
ROS (17). Under control conditions, all LDHA- and PDK1overexpressing cells showed significantly less mitochondrial
ROS, as measured by mean MTR fluorescence, when compared
with the control cells expressing an empty vector (Fig. 3. p ⬍
0.01). Moreover, LDHA- and PDK1-overexpressing cell lines
exhibited significantly lower levels of mitochondrial ROS when
treated with A␤ (20 M) for 48 h compared with the vector
control cells (Fig. 4). In contrast, the parental cells expressing
vector alone showed a significant increase in mitochondrial
ROS following exposure to A␤(p ⬍ 0.01). Similarly, LDHA- and
OCTOBER 26, 2012 • VOLUME 287 • NUMBER 44

PDK1-overexpressing cells generated significantly less mitochondrial ROS when exposed to either H2O2 or staurosporine
for 30 min compared with vector control cells treated in the
same manner. Similar results were obtained using MitoSOX, a
mitochondrion-specific superoxide indicator (supplemental
Fig. 2). Thus, overexpression of either LDHA or PDK1 resulted
in a significant reduction in mitochondrial ROS, which is maintained following toxin exposure.
Overall, cellular ROS levels have been previously shown to
increase when cells are treated with stressors such as A␤ (6,
8). We therefore sought to examine if the cellular levels of
ROS were altered in B12 cells overexpressing LDHA or
PDK1. We used the live cell fluorescent ROS indicator
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. Respiration is decreased but ATP levels are maintained in cells overexpressing LDHA and PDK1. A, oxygen consumption was monitored in B12
cell lines using the MitoXpress-Xtra-HS fluorescent probe. All clonal cell lines overexpressing LDHA and PDK1 displayed significantly lower levels of oxygen
consumption under control conditions compared with cells expressing an empty vector (pcDNA) (*, p ⬍ 0.05; **, p ⬍ 0.01). Oxygen consumption significantly
decreased in pcDNA control cells following 48 h of treatment with A␤(25–35) (20 M) compared with untreated conditions (#, p ⬍ 0.05). In contrast, cells
overexpressing LDHA or PDK1 maintain or increase their oxygen consumption following 48 h of A␤ exposure. B, representative example of oxygen consumption over time for the indicated B12 cell lines. C, representative example of oxygen consumption over time following 48 h of A␤(25–35) (20 M) treatment.
D, cells overexpressing LDHA or PDK1 had similar levels of ATP when compared with control cells under normal culture conditions. Cells expressing empty
vector had significantly lower levels of ATP following exposure to A␤ (#, p ⬍ 0.05), whereas LDHA- and PDK1-overexpressing cells maintained significantly
higher ATP levels than the control following treatment with A␤ (*, p ⬍ 0.05). Data represent the average ⫾ S.D. of three independent experiments. Data were
analyzed by a one-way ANOVA followed by a Tukey test.

H2DCFDA to determine the overall levels of ROS. Under
control conditions, cells overexpressing either LDHA or
PDK1 showed significantly decreased basal levels of ROS
when compared with the parental cell expressing the empty
vector (supplemental Fig. 3, p ⬍ 0.01). Interestingly, significantly lower levels of ROS were maintained in these cells
when exposed to A␤, H2O2, or staurosporine (supplemental
Fig. 3, p ⬍ 0.01). In contrast, B12 cells expressing empty
vector alone exhibited a significant increase in cellular ROS
following 48 h of exposure to A␤ or when treated with either
H2O2 or staurosporine for 24 h (supplemental Fig. 3, p ⬍
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0.01). Thus, cells overexpressing either LDHA or PDK1
exhibit lower levels of both mitochondrial and cellular ROS
when compared with control cells, which likely contributes
to their broad resistance to oxidant-promoting neurotoxins.
Decreased LDHA and PDK1 Expression in Primary Nerve
Cells following Exposure to A␤—Expression of both PDK1 and
LDHA in wild type mouse primary cortical nerve cell cultures
was examined following A␤ exposure over a 48-h period (Fig.
5). A significant decrease in the expression of both these proteins was observed by 48 h following exposure to A␤ when
compared with untreated cells harvested at the same time
VOLUME 287 • NUMBER 44 • OCTOBER 26, 2012
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FIGURE 4. Decreased mitochondrial ROS in LDHA- and PDK 1-overexpressing cells. Top panels, mitochondrial ROS production was measured in B12 cell
lines following labeling with the red fluorescent dye MitoTracker-ROS Red (MTR). B12 clonal cell lines overexpressing PDK1 or LDHA exhibited a significant
reduction in mitochondrial ROS (red) compared with the parental (pcDNA) cell line expressing the empty vector under both normal culture conditions and
following exposure to A␤(25–35)(20 M), H2O2 (200 M), or staurosporine (200 ng/ml) for the indicated time periods. Nuclei were stained with Hoescht (blue)
and visualized by fluorescence microscopy at ⫻400 magnification. Bottom panels, quantification of MTR fluorescent images revealed that mitochondrial ROS
production was significantly decreased in PDK1- or LDHA-overexpressing cell lines compared with the pcDNA control line (*, p ⬍ 0.05; **, p ⬍ 0.01). Data
presented are the average of three independent experiments.

points. Decreased PDK1 and LDHA expression was unlikely
due to loss of cells because minimal cell death was observed up
to 48 h (data not shown). Therefore, it appears that A␤ exposure inhibits expression of Warburg effect enzymes in primary
neurons.
Decreased LDHA and PDK1 Expression in tg-AD Mice at 12
Months—The APPswe/PSEN1dE9 double transgenic mouse
strain (tg-AD) exhibits pronounced amyloid plaque accumulation and memory deficits at 12 months of age compared with
age-matched controls (38, 39). Based on the neuroprotective
properties of PDK1 and LDHA in culture, we sought to determine whether the levels of both enzymes were altered in cortical extracts from tg-AD mice relative to non-tg littermate conOCTOBER 26, 2012 • VOLUME 287 • NUMBER 44

trols. Immunoblot analysis (Fig. 6) revealed a significant
reduction in overall levels of LDHA and PDK1 in tg-AD mice
compared with controls (p ⬍ 0.001).
Decreased PDK1 Expression in Human AD Cortical Samples—
It has been shown previously that glycolytic activity and
enzymes involved in glycolysis are up-regulated in the AD brain
(15). We therefore examined the levels of LDHA and PDK1 in
extracts from post-mortem control and AD frontal cortex tissue. We observed no significant difference in the overall protein
levels of LDHA (data not shown). However, a significant
decrease in PDK1 protein expression was detected in AD brain
samples when compared with age-matched controls (Fig. 7, p ⬍
0.01).
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FIGURE 5. A␤ exposure inhibits expression of Warburg effect enzymes in mouse primary cortical neurons. A, primary cortical nerve cell cultures were
exposed to A␤(25–35) (10 M) and harvested at the indicated time points over a 48-h period. Western blot analysis revealed that both PDK1 and LDHA
expressions are decreased in cortical neurons exposed to A␤ compared with untreated cells. Densitometric analyses of PDK1 (B) and LDHA (C) band intensities
are indicated. A significant decrease in both PDK1 and LDHA expression in A␤-treated cells was observed by 48 h (*, 0.05 p ⬍ 0.05; **, p ⬍ 0.01). Data represent
the average ⫾ S.D. of three independent experiments. Data were analyzed by a one-way ANOVA, and significant differences between means were determined
by contrasts.

FIGURE 6. PDK1 and LDHA protein levels are decreased in APPswe/PSEN1dE9 double transgenic (tg-AD) mouse brains. Top panels, immunoblot analysis
of cortical extracts from 12-month-old mice revealed that PDK1 and LDHA protein levels were markedly decreased in tg-AD mice when compared with
nontransgenic littermate controls. Bottom panel, densitometric analysis of the above immunoblots revealed significantly decreased PDK1 and LDHA expression in tg-AD mice compared with littermate controls (*, p ⬍ 0.001).

DISCUSSION
Mitochondrial Membrane Potential, ROS Production, and
A␤ Sensitivity—Mitochondrial dysfunction is a hallmark of AD,
and it is thought to be central to A␤ toxicity. ROS can be produced by the leakage of electrons from the mitochondrial ETC,
which results in the partial reduction of molecular oxygen and
the subsequent generation of superoxide radicals (O2. ). Chronic
increases in ROS production, as seen in AD, can lead to the
oxidation and damage of macromolecules such as proteins, lipids, and nucleic acids and is strongly associated with the induction of apoptosis. Interestingly, cells depleted of mitochondrial
DNA lacking critical subunits of the respiratory chain are not
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sensitive to the toxic effects of A␤ suggesting that A␤ relies on
a functional mitochondrial respiratory chain to elicit toxicity
(39). A␤ has been shown to accumulate within the mitochondria of AD patients and transgenic mice (40 – 43). The direct
binding A␤ to the mitochondrial protein alcohol dehydrogenase (ABAD) promotes leakage of electrons, mitochondrial dysfunction, increased ROS production, and ultimately cell death
(41). However, overexpression of the mitochondrial antioxidant enzyme manganese superoxide dismutase in tg-AD mice
improved resistance to A␤ and attenuated the AD phenotype,
suggesting that mitochondrial toxicity is central to A␤-induced
cell death (44). Here, we show that overexpression of LDHA or
VOLUME 287 • NUMBER 44 • OCTOBER 26, 2012
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FIGURE 7. PDK1 is decreased in cortical extracts from AD patients. Top
panels, immunoblot analysis of post-mortem human cortical extracts
revealed decreased PDK1 levels in human AD brain samples (A1–A7) when
compared with the age- and sex-matched controls (1–7). Bottom panel, densitometric analysis of the above blot revealed a significant decrease in PDK1
expression in AD patients compared with controls (*, p ⬍ 0.01).

PDK1 in nerve cells results in both decreased ⌬m and O2
consumption, which is associated with reduced mitochondrial
ROS production and attenuated cell death following exposure
to various toxins, including A␤. Interestingly, the reduction in
mitochondrial respiration does not appear to negatively affect
ATP levels in cells overexpressing LDHA or PDK1. These cells
are likely able to maintain high levels of cellular ATP through
increased flux through the glycolytic pathway, similar to A␤-resistant cells (15). We propose that decreased ETC activity and
ROS production associated with LDHA and PDK1 expression is
central to conferring protection against A␤ and other toxins.
This is further supported by the observation that knockdown of
either LDHA or PDK1 in B12 cells further potentiated sensitivity to A␤ and other neurotoxins. Moreover, genetic silencing of
either LDHA or PDK1 in A␤-resistant cells resulted in re-sensitization to A␤ toxicity, suggesting that these enzymes play an
important role in protecting cells against A␤ toxicity (28).
Protective Role of LDHA and PDK1—Elevated LDHA and
PDK1 expression may confer resistance to A␤, H2O2, and staurosporine by a variety of mechanisms. Although A␤ is known to
trigger an increase in H2O2 production resulting in free radical
damage and cell death, H2O2 accumulation is not observed in
A␤-resistant cells (13). Moreover, cells selected for resistance
against A␤ toxicity are also resistant to exogenously applied
H2O2 and neurotoxins known to induce oxidative stress, suggesting that A␤ and H2O2 promote cell death by a similar
mechanism (13, 14). Additionally, the observation that pretreatment of CNS primary cultures or PC12 and B12 cells with
catalase, an antioxidant that detoxifies H2O2, results in protection against A␤-induced cell death further suggests that H2O2
mediates A␤ toxicity (6). H2O2 treatment has been shown to
induce transient ⌬m hyperpolarization and a subsequent
delayed burst of endogenous ROS in mouse primary neurons
and human neuroblastoma cells. Furthermore, chemical inhibition of mitochondrial hyperpolarization was shown to protect neuronal cells from oxidative stress-induced cell death
(45). In our study, PDK1 or LDHA overexpression also prevented the transient increase in ⌬m following H2O2 exposure.
OCTOBER 26, 2012 • VOLUME 287 • NUMBER 44

Interestingly, overexpression of LDHA or PDK1 also resulted
in increased resistance to staurosporine, an apoptosis-inducing
agent that was initially believed to promote toxicity in a ROSindependent manner (46). Staurosporine has been well characterized as a potent inducer of apoptosis through inhibition of
protein kinases (46, 47). However, several studies have shown
that staurosporine-induced apoptosis in neurons is partly
dependent on mitochondrion-derived ROS (48 –50). Given
that oxidative stress is tightly associated with A␤- and H2O2induced cell death, overexpression of LDHA or PDK1 is likely
to protect cells by reducing mitochondrial ETC activity and
associated ROS production.
In this study, we observed decreased ⌬m and O2 consumption in cells overexpressing LDHA or PDK1 compared with
control cells, which was maintained following toxin exposure.
In contrast, control cells underwent a sharp increase in ⌬m
followed by rapid depolarization and cell death in the presence
of all toxins. A positive ⌬m is created by the ETC that transfers
protons (H⫹) into the intermembrane space. The resulting
electrochemical gradient is subsequently used to synthesize
ATP. Thus, if ETC activity is low, in the case of reduced mitochondrial respiration, then ⌬m would also be low. Loss of
⌬m altogether mediates the release of proapoptotic factors
through the mitochondrial transition pore. In cells overexpressing PDK1, the observed decrease in ⌬m and O2 consumption is likely reflective of a decrease in ETC activity as a
result of pyruvate dehydrogenase inhibition (23). PDK1-mediated inhibition of pyruvate dehydrogenase results in decreased
entry of pyruvate into the TCA cycle and a subsequent decrease
in the production of the electron donors NADH and FADH2
necessary for ETC activity. In LDHA-overexpressing cells,
LDHA competes with the mitochondrial NADH/NAD⫹ shuttle systems to regenerate NAD⫹ (51). Therefore, the overexpression of LDHA or PDK1 likely limits the availability of both
pyruvate and NADH in the mitochondria thereby decreasing
respiration and ⌬m (36).
Previous studies revealed that more ROS is generated at
higher mitochondrial membrane potentials, with dramatic
increases in ROS being produced when mitochondrial membranes reach potentials of 140 mV or more (52). Conversely a
small decrease (10 mV) in ⌬m significantly attenuates ROS
production (up to 70%) via complex I of the ETC, suggesting
that moderate attenuation of membrane potential can result in
significant changes in the oxidative potential of the cell (53).
Interestingly, we observed that cells overexpressing LDHA or
PDK1 exhibited decreased mitochondrial membrane potentials
with or without exposure to toxins, which likely contributed to
their resistance through the associated decrease in mitochondrial ROS. Moreover, the observed hyperpolarization prior to
depolarization and cell death in H2O2-exposed control cells
was likely associated with a burst in ROS production. Collectively, our findings suggest that cells exhibiting a lower ⌬m
and decreased mitochondrial ROS production under basal conditions may have a unique advantage over cells exhibiting
higher ⌬m when faced with a toxic stressor such as A␤.
Glucose Metabolism in the AD Brain—Recent [18F]FDG PET
imaging studies in tg-AD (APPSweLon/PS1M146L) mice revealed
a dynamic picture of glucose utilization within the brain (54). In
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3-, 6-, and 12-month-old tg-AD mice, it was found that there
was an age-dependent increase in glucose uptake in the cortex,
hippocampus, and striatum, areas associated with high plaque
accumulation (54). However, this study did not discern what
proportion of glucose was processed by aerobic glycolysis versus mitochondrial respiration. Here, we looked at 12-monthold APP/PS1 mice and observed a decrease in both LDHA and
PDK1 expression in the frontal cortex when compared with
age-matched controls. Thus, it is possible that at early stages of
pathogenesis in tg-AD mice, nerve cells exploit the Warburg
effect and increase glucose uptake to protect against A␤ toxicity. However, if LDHA and PDK1 expression decreases in older
mice then more glycolytic flux would be processed through the
mitochondria leading to increased ROS production, elevated
apoptosis, and ultimately cognitive impairment. A more intensive longitudinal study of the Warburg effect in AD mice is
necessary to offer more insight into the metabolic state of
affected neurons.
Interestingly, a study measuring the regional distribution of
aerobic glycolysis in the human brain revealed that areas most
susceptible to amyloid toxicity exhibit high aerobic glycolysis
(30). In the developing nervous system, aerobic glycolysis is
believed to account for 90% of glucose consumed (55). During
childhood, this fraction accounts for 35% of glucose utilization
and finally drops to 10 –12% in the adult brain (31). PET studies
of cognitively normal individuals have shown an age-associated decrease in FDG uptake in regions of the brain frequently affected in AD, although these studies did not determine what proportion of glucose was processed by aerobic
glycolysis versus oxidative phosphorylation (56). However, a
recent neuroimaging study revealed a strong correlation
between the spatial distribution of A␤ deposition and aerobic glycolysis in both cognitively normal individuals and AD
patients (30). Thus, aerobic glycolysis may be elevated in
areas of the brain most susceptible to insult as a pre-emptive
protective mechanism or in response to A␤ accumulation
during aging (Fig. 8). Loss of this protective mechanism may
render certain areas of the brain susceptible to A␤-induced
neurotoxicity.
In this study, we looked at AD post-mortem tissue and
observed a decrease in PDK1 expression in the frontal cortex.
Decreased PDK1 expression may contribute to loss of aerobic
glycolysis in brain areas with A␤ deposition which, in turn, may
trigger an increase in mitochondrial respiration, ROS production, and nerve cell death. A recent study showed that inhibition of respiratory complexes in a cell culture model leads to an
increase in both ROS and A␤ production, further potentiating
toxicity (57). Similarly, AD mice treated with a complex I inhibitor also exhibit an increase in A␤ levels (57). In both models,
ROS-dependent accumulation of A␤ was reduced by treatment
with antioxidants. Therefore, mitochondrial ROS production
appears to be tightly associated with A␤ production in vitro and
in vivo (57). The decreased ROS production afforded by the
Warburg effect may not only be intrinsically neuroprotective
but may actually attenuate A␤ production in AD. In future
studies it will be important to perform immunohistochemical
analysis on brain tissues to determine the spatial relationship
between PDK1 expression and A␤ deposition.
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FIGURE 8. Proposed model describing the relationship between aerobic
glycolysis and AD. In the normal young adult brain, aerobic glycolysis (the
Warburg effect) is elevated in regions known to be susceptible to A␤ deposition. Aerobic glycolysis is maintained, in part, by increased lactate dehydrogenase A (LDHA) and pyruvate dehydrogenase kinase 1 (PDK1) expression.
LDHA converts pyruvate to lactate with the concomitant regeneration of nicotinamide (NAD⫹) which is necessary to sustain glycolysis. PDK1 phosphorylates and inhibits pyruvate dehydrogenase resulting in decreased OXPHOS,
mitochondrial membrane potential (⌬m), and ROS production. The ageassociated increase in A␤ deposition and concomitant decrease in aerobic
glycolysis may render certain populations of neurons vulnerable to A␤ toxicity in the elderly. In cognitively normal individuals, gradual A␤ deposition
triggers increased expression of LDHA and PDK1 resulting in elevated aerobic
glycolysis, lowered ⌬m, and diminished ROS. As a result of increased aerobic
glycolysis, nerve cells become resistant to A␤ toxicity. In individuals who
develop Alzheimer disease, the inability to either activate or maintain aerobic
glycolysis renders nerve cells more susceptible to A␤-mediated mitochondrial dysfunction and increased ROS production leading to synaptic loss and
ultimately widespread nerve cell death.

Although we propose that glucose is the main fuel source for
A␤-resistant neurons, alternative substrates, such as lactate,
may be also used to meet the energy demands of brain cells. The
astrocyte-neuron lactate shuttle theory postulates that glucose
is predominantly taken up by glia and metabolized glycolytically to lactate, which is subsequently secreted and taken up by
neurons (58). In neurons, lactate is converted to pyruvate which
enters the TCA cycle and drives oxidative phosphorylation.
Studies in our laboratory have shown that addition of lactate to
the culture media of either PC12 or B12 cells failed to alleviate
A␤ sensitivity.4 Furthermore, exogenous lactate failed to rescue
the elevated sensitivity of A␤-resistant PC12 and B12 clonal
nerve cell lines to glucose deprivation.4 These findings suggest
that exogenous lactate itself is unlikely to fuel the neuroprotective response associated with aerobic glycolysis.
Conclusions—PDK1 and LDHA appear to be central mediators
of A␤ resistance by altering mitochondrial activity that results in a
decrease in both ⌬m and mitochondrial ROS production. In
addition, overexpression of either of these enzymes confers resistance to other stressors, including H2O2 and staurosporine. Overexpression of these key Warburg effect enzymes decreases mitochondrial respiration while maintaining ATP production that
appears to contribute to the protective role of these proteins.
Decreased expression of LDHA and PDK1 in mouse primary cortical neurons may also contribute to their sensitivity to A␤. Likewise, decreased expression of both LDHA and PDK1 in 12-monthold tg-AD (APP/PS1) mice suggests that loss of this neuroprotective mechanism may potentiate cognitive impairment. Loss
4

J. T. Newington, T. Rappon, and R. C. Cumming, unpublished observations.
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of PDK1-mediated aerobic glycolysis in AD patients may hasten
both memory loss and nerve cell death and could be used as a
biomarker of disease progression. Moreover, identification of
compounds that mimic or augment PDK1 activity may have clinical relevance for the treatment of AD.

20.

21.

Acknowledgments—We thank Dr. David Schubert at The Salk Institute, La Jolla, CA, for the generous donation of the B12 cell line and
tissue samples. We also thank Dr. Jim Staples, Dr. Louise Milligan,
and Dr. Ronald Podesta from the Department of Biology at the University of Western Ontario for technical assistance.

REFERENCES
1. Selkoe, D. J. (2004) Alzheimer disease. Mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140, 627– 638
2. Selkoe, D. J. (1998) The cell biology of ␤-amyloid precursor protein and
presenilin in Alzheimer disease. Trends Cell Biol. 8, 447– 453
3. Selkoe, D. J. (1991) The molecular pathology of Alzheimer disease. Neuron
6, 487– 498
4. Hardy, J. A., and Higgins, G. A. (1992) Alzheimer disease. The amyloid
cascade hypothesis. Science 256, 184 –185
5. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E.
(2011) Alzheimer disease. Lancet 377, 1019 –1031
6. Behl, C., Davis, J. B., Lesley, R., and Schubert, D. (1994) Hydrogen peroxide
mediates amyloid ␤ protein toxicity. Cell 77, 817– 827
7. Tillement, L., Lecanu, L., and Papadopoulos, V. (2011) Alzheimer disease.
Effects of ␤-amyloid on mitochondria. Mitochondrion 11, 13–21
8. Butterfield, D. A., Reed, T., Newman, S. F., and Sultana, R. (2007) Roles of
amyloid ␤-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer disease and mild cognitive impairment. Free Radic. Biol. Med. 43, 658 – 677
9. Markesbery, W. R. (1997) Oxidative stress hypothesis in Alzheimer disease. Free Radic. Biol. Med. 23, 134 –147
10. Bouras, C., Hof, P. R., Giannakopoulos, P., Michel, J. P., and Morrison, J. H.
(1994) Regional distribution of neurofibrillary tangles and senile plaques
in the cerebral cortex of elderly patients. A quantitative evaluation of a
one-year autopsy population from a geriatric hospital. Cereb. Cortex 4,
138 –150
11. Price, J. L., and Morris, J. C. (1999) Tangles and plaques in nondemented
aging and “preclinical” Alzheimer disease. Ann. Neurol. 45, 358 –368
12. Cumming, R. C., Dargusch, R., Fischer, W. H., and Schubert, D. (2007)
Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid ␤-resistant nerve cells. J. Biol. Chem. 282,
30523–30534
13. Sagara, Y., Dargusch, R., Klier, F. G., Schubert, D., and Behl, C. (1996)
Increased antioxidant enzyme activity in amyloid ␤ protein-resistant cells.
J. Neurosci. 16, 497–505
14. Dargusch, R., and Schubert, D. (2002) Specificity of resistance to oxidative
stress. J. Neurochem. 81, 1394 –1400
15. Soucek, T., Cumming, R., Dargusch, R., Maher, P., and Schubert, D. (2003)
The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid ␤ peptide. Neuron 39, 43–56
16. Warburg, O. (1956) On the origin of cancer cells. Science 123, 309 –314
17. Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C.,
Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S.,
Harry, G., Hashimoto, K., Porter, C. J., Andrade, M. A., Thebaud, B., and
Michelakis, E. D. (2007) A mitochondria-K⫹ channel axis is suppressed in
cancer and its normalization promotes apoptosis and inhibits cancer
growth. Cancer Cell 11, 37–51
18. Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M.,
Royer, R. E., Vander Jagt, D. L., Semenza, G. L., and Dang, C. V. (2010)
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits
tumor progression. Proc. Natl. Acad. Sci. U.S.A. 107, 2037–2042
19. Zhou, M., Zhao, Y., Ding, Y., Liu, H., Liu, Z., Fodstad, O., Riker, A. I.,
Kamarajugadda, S., Lu, J., Owen, L. B., Ledoux, S. P., and Tan, M. (2010)

OCTOBER 26, 2012 • VOLUME 287 • NUMBER 44

22.

23.

24.
25.

26.

27.

28.

29.

30.

31.

32.

33.

34.
35.

36.

37.

38.

39.

Warburg effect in chemosensitivity. Targeting lactate dehydrogenase A
re-sensitizes taxol-resistant cancer cells to taxol. Mol. Cancer 9, 33
Kim, J. W., Tchernyshyov, I., Semenza, G. L., and Dang, C. V. (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase. A metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3,
177–185
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., and Denko, N. C.
(2006) HIF-1 mediates adaptation to hypoxia by actively down-regulating
mitochondrial oxygen consumption. Cell Metab. 3, 187–197
Semenza, G. L., Jiang, B. H., Leung, S. W., Passantino, R., Concordet, J. P.,
Maire, P., and Giallongo, A. (1996) Hypoxia-response elements in the
aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem.
271, 32529 –32537
McFate, T., Mohyeldin, A., Lu, H., Thakar, J., Henriques, J., Halim, N. D.,
Wu, H., Schell, M. J., Tsang, T. M., Teahan, O., Zhou, S., Califano, J. A.,
Jeoung, N. H., Harris, R. A., and Verma, A. (2008) Pyruvate dehydrogenase
complex activity controls metabolic and malignant phenotype in cancer
cells. J. Biol. Chem. 283, 22700 –22708
Semenza, G. L. (2010) HIF-1. Upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev. 20, 51–56
Lu, H., Dalgard, C. L., Mohyeldin, A., McFate, T., Tait, A. S., and Verma, A.
(2005) Reversible inactivation of HIF-1 prolyl hydroxylases allows cell
metabolism to control basal HIF-1. J. Biol. Chem. 280, 41928 – 41939
Lu, H., Forbes, R. A., and Verma, A. (2002) Hypoxia-inducible factor 1
activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem. 277, 23111–23115
Koppenol, W. H., Bounds, P. L., and Dang, C. V. (2011) Otto Warburg’s
contributions to current concepts of cancer metabolism. Nat. Rev. Cancer
11, 325–337
Newington, J. T., Pitts, A., Chien, A., Arseneault, R., Schubert, D., and
Cumming, R. C. (2011) Amyloid ␤ resistance in nerve cell lines is mediated
by the Warburg effect. PLoS One 6, e19191
Mosconi, L. (2005) Brain glucose metabolism in the early and specific
diagnosis of Alzheimer disease. FDG-PET studies in MCI and AD. Eur.
J. Nucl. Med. Mol. Imaging 32, 486 –510
Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J.,
Mach, R. H., Morris, J. C., Raichle, M. E., and Mintun, M. A. (2010) Spatial
correlation between brain aerobic glycolysis and amyloid-␤ (A␤) deposition. Proc. Natl. Acad. Sci. U.S.A. 107, 17763–17767
Vaishnavi, S. N., Vlassenko, A. G., Rundle, M. M., Snyder, A. Z., Mintun,
M. A., and Raichle, M. E. (2010) Regional aerobic glycolysis in the human
brain. Proc. Natl. Acad. Sci. U.S.A. 107, 17757–17762
Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Patrick,
J., Steinbach, J. H., Culp, W., and Brandt, B. L. (1974) Clonal cell lines from
the rat central nervous system. Nature 249, 224 –227
Hansen, M. B., Nielsen, S. E., and Berg, K. (1989) Re-examination and
further development of a precise and rapid dye method for measuring cell
growth/cell kill. J. Immunol. Methods 119, 203–210
Hynes, J., Swiss, R. L., and Will, Y. (2012) High throughput analysis of
mitochondrial oxygen consumption. Methods Mol. Biol. 810, 59 –72
Ribeiro, F. M., Black, S. A., Cregan, S. P., Prado, V. F., Prado, M. A., Rylett,
R. J., and Ferguson, S. S. (2005) Constitutive high affinity choline transporter endocytosis is determined by a carboxyl-terminal tail dileucine
motif. J. Neurochem. 94, 86 –96
Fantin, V. R., St-Pierre, J., and Leder, P. (2006) Attenuation of LDH-A
expression uncovers a link between glycolysis, mitochondrial physiology,
and tumor maintenance. Cancer Cell 9, 425– 434
Michelakis, E. D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A.,
Niven, E., Maguire, C., Gammer, T. L., Mackey, J. R., Fulton, D., Abdulkarim, B., McMurtry, M. S., and Petruk, K. C. (2010) Metabolic modulation
of glioblastoma with dichloroacetate. Sci. Transl. Med. 2, 31ra34
Dineley, K. T., Xia, X., Bui, D., Sweatt, J. D., and Zheng, H. (2002) Accelerated plaque accumulation, associative learning deficits, and up-regulation of ␣7 nicotinic receptor protein in transgenic mice co-expressing
mutant human presenilin 1 and amyloid precursor proteins. J. Biol. Chem.
277, 22768 –22780
Cardoso, S. M., Santos, S., Swerdlow, R. H., and Oliveira, C. R. (2001)

JOURNAL OF BIOLOGICAL CHEMISTRY

37257

PDK1 and LDHA Mediate Resistance to A␤

40.

41.

42.

43.

44.

45.

46.

47.

48.

49.

Functional mitochondria are required for amyloid ␤-mediated neurotoxicity. FASEB J. 15, 1439 –1441
Fernández-Vizarra, P., Fernández, A. P., Castro-Blanco, S., Serrano, J.,
Bentura, M. L., Martínez-Murillo, R., Martínez, A., and Rodrigo, J. (2004)
Intra- and extracellular A␤ and PHF in clinically evaluated cases of Alzheimer disease. Histol. Histopathol. 19, 823– 844
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N.,
Caspersen, C., Chen, X., Pollak, S., Chaney, M., Trinchese, F., Liu, S.,
Gunn-Moore, F., Lue, L. F., Walker, D. G., Kuppusamy, P., Zewier, Z. L.,
Arancio, O., Stern, D., Yan, S. S., and Wu, H. (2004) ABAD directly links
A␤ to mitochondrial toxicity in Alzheimer disease. Science 304, 448 – 452
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., and
Reddy, P. H. (2006) Mitochondria are a direct site of A␤ accumulation in
Alzheimer disease neurons. Implications for free radical generation and
oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437–1449
Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W.,
Xu, H. W., Stern, D., McKhann, G., and Yan, S. D. (2005) Mitochondrial
A␤. A potential focal point for neuronal metabolic dysfunction in Alzheimer disease. FASEB J. 19, 2040 –2041
Dumont, M., Wille, E., Stack, C., Calingasan, N. Y., Beal, M. F., and Lin,
M. T. (2009) Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer disease. FASEB J. 23, 2459 –2466
Choi, K., Kim, J., Kim, G. W., and Choi, C. (2009) Oxidative stress-induced
necrotic cell death via mitochondria-dependent burst of reactive oxygen
species. Curr. Neurovasc. Res. 6, 213–222
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